Cholesterol suppresses human iTreg differentiation and nTreg function through mitochondria-related mechanisms
Authors:
Open Access
- 27 March 2023
- journal article
- research article
- Published by Springer Nature in Journal of Translational Medicine
- Vol. 21 (1) , 1-18
Abstract
Background: Both the crystalline and soluble forms of cholesterol increase macrophage secretion of interleukin 1β (IL-1β), aggravating the inflammatory response in atherosclerosis (AS). However, the link between cholesterol and regulatory T cells (Tregs) remains unclear. This study aimed to investigate the effect of cholesterol treatment on Tregs. Methods: Differentiation of induced Tregs (iTregs) was analyzed using flow cytometry. The expression of hypoxia-inducible factor-1a (HIF-1a) and its target genes was measured by western blotting and/or RT-qPCR. Two reporter jurkat cell lines were constructed by lentiviral transfection. Mitochondrial function and the structure of natural Tregs (nTregs) were determined by tetramethylrhodamine (TMRM) and mitoSOX staining, Seahorse assay, and electron microscopy. The immunoregulatory function of nTregs was determined by nTreg-macrophage co-culture assay and ELISA. Results: Cholesterol treatment suppressed iTreg differentiation and impaired nTreg function. Mechanistically, cholesterol induced the production of mitochondrial reactive oxygen species (mtROS) in naïve T cells, inhibiting the degradation of HIF-1α and unleashing its inhibitory effects on iTreg differentiation. Furthermore, cholesterol-induced mitochondrial oxidative damage impaired the immunosuppressive function of nTregs. Mixed lymphocyte reaction and nTreg-macrophage co-culture assays revealed that cholesterol treatment compromised the ability of nTregs to inhibit pro-inflammatory conventional T cell proliferation and promote the anti-inflammatory functions of macrophages. Finally, mitoTEMPO (MT), a specific mtROS scavenger, restored iTreg differentiation and protected nTreg from further deterioration. Conclusion: Our findings suggest that cholesterol may aggravate inflammation within AS plaques by acting on both iTregs and nTregs, and that MT may be a promising anti-atherogenic drug.Keywords
Funding Information
- Innovative Research Group Project of the National Natural Science Foundation of China (81720108005)
- National Natural Science Foundation of China (82170282)
This publication has 50 references indexed in Scilit:
- mTORC1 couples immune signals and metabolic programming to establish Treg-cell functionNature, 2013
- Sterol regulatory element–binding proteins are essential for the metabolic programming of effector T cells and adaptive immunityNature Immunology, 2013
- Control of TH17/Treg Balance by Hypoxia-Inducible Factor 1Cell, 2011
- The role of CD4+CD25+ regulatory T cells in macrophage-derived foam-cell formationJournal of Lipid Research, 2010
- NLRP3 inflammasomes are required for atherogenesis and activated by cholesterol crystalsNature, 2010
- Free cholesterol overloading induced smooth muscle cells death and activated both ER- and mitochondrial-dependent death pathwayAtherosclerosis, 2009
- Protein geranylgeranylation regulates the balance between Th17 cells and Foxp3+ regulatory T cellsInternational Immunology, 2009
- LXR Signaling Couples Sterol Metabolism to Proliferation in the Acquired Immune ResponseCell, 2008
- CD4+CD25+Foxp3+regulatory T cells induce alternative activation of human monocytes/macrophagesProceedings of the National Academy of Sciences, 2007
- Mouse model for noninvasive imaging of HIF prolyl hydroxylase activity: Assessment of an oral agent that stimulates erythropoietin productionProceedings of the National Academy of Sciences, 2005